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Arch and visceral/renal debranching combined
with endovascular repair for thoracic and
thoracoabdominal aortic aneurysms
Sung Wan Ham, MD,a Terry Chong, MD,a John Moos, MD,a Vincent L. Rowe, MD,a
Robbin G. Cohen, MD,a Mark J. Cunningham, MD,a Alison Wilcox, MD,b and
Fred A. Weaver, MD, MMM,a Los Angeles, Calif
Objective:We report a single-center experience using the hybrid procedure, consisting of open debranching, followed by
endovascular aortic repair, for treatment of arch/proximal descending thoracic/thoracoabdominal aortic aneurysms
(TAAA).
Methods: From 2005 to 2010, 51 patients (33 men; mean age, 70 years) underwent a hybrid procedure for arch/proximal
descending thoracic/TAAA. The 30-day and in-hospital morbidity and mortality rates, and late endoleak, graft patency,
and survival were analyzed. Graft patency was assessed by computed tomography, angiography, or duplex ultrasound
imaging.
Results: Hybrid procedures were used to treat 27 thoracic (16 arch, 11 proximal descending thoracic) and 24 TAAA
(Crawford/Safi types I to III: 3; type IV: 12; type V: 9). The hybrid procedure involved debranching 47 arch vessels or
77 visceral/renal vessels using bypass grafts, followed by endovascular repair. Seventy-five percent of debranching and
endovascular repair procedures were staged, with an average interval of 28 days. Major 30-day and in-hospital
complications occurred in 39% of patients and included bypass graft occlusion in four, endoleak reintervention in two,
and paraplegia in one. Mortality was 3.9%. During a mean follow-up of 13 months, three additional type II endoleaks
required intervention, and one bypass graft occluded. No aneurysm rupture occurred during follow-up. Primary bypass
graft patency was 95.3%. Actuarial survival was 86% at 1 year and 67% at 3 years.
Conclusion: The hybrid procedure is associated with acceptable rates of mortality and paraplegia when used for treatment
of arch/proximal descending thoracic/TAAA. These results support this procedure as a reasonable approach to a difficult
surgical problem; however, longer follow-up is required to appraise its ultimate clinical utility. ( J Vasc Surg 2011;54:
30-41.)
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rHybrid surgical approaches that involve open surgical
debranching of the arch or visceral/renal vessels, or both,
followed by endovascular repair, has emerged as an alter-
native to conventional open repair of aortic aneurysms that
involve the arch and the visceral/renal aorta. Clinical out-
come data for hybrid procedures are limited to early single-
center experiences that exhibit wide variability in results.
Therefore, clear indications for its use are still evolving.
The hybrid approach has been generally applied to
patients who are at high risk for standard open repair. It
offers a less invasive and potentially safer approach to pa-
tients who are poor surgical candidates due to marginal
cardiac, pulmonary, or renal reserve, or complex aortic
anatomy. More recently, however, selected centers have
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30eported use of the hybrid repair as a preferential option,
ven in low-risk patients, because of its imputed superior
afety.1
This shift in the treatment paradigm from traditional
pen repair to the innovative use of combined open and
ndovascular techniques prompted us to review our own
xperience using the hybrid approach in patients with com-
lex aneurysms that involve the arch or visceral/renal aorta,
r both.
ETHODS
A retrospective review was performed of all hybrid
rocedures performed at the University of Southern Cali-
ornia Hospitals from 2005 to 2010. Patients with arch,
roximal descending thoracic aneurysm (PDTA) or thora-
oabdominal aortic aneurysm (TAAA) who underwent
rch or visceral/renal debranching with subsequent endo-
ascular exclusion of the aneurysm were entered into a
rospectively maintained database that was retrospectively
eviewed. All patient records were reviewed with the ap-
roval of the University of Southern California Health
ciences Institutional Review Board.
Patient demographic data and preoperative clinical data
ere collected, including comorbidities, symptoms, aneu-
ysm extent, and indication for operation. Aneurysm size
nd Crawford/Safi extent of disease was determined based
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Volume 54, Number 1 Ham et al 31on 3-dimensional reconstructions of preoperative com-
puted tomography (CT) scans, using the cross-sectional
diameter of the aortic centerline. The minor axis was used
when reconstructions were unavailable and for all follow-up
studies. Operative details included the debranching tech-
nique, vascular access, delivery method, and intraoperative
complications. The modified Society for Vascular Surgery
(SVS) risk score was used to stratify patient operative risk.
Postoperative hospital course and associated 30-day or
in-hospital morbidity and mortality were recorded accord-
ing to published reporting standards by the Ad Hoc Com-
mittee for the Standardized Reporting Practices in Vascular
Surgery of the SVS.2
Patients were grouped and analyzed into one of three
categories by anatomic aneurysm extent and vessel involve-
ment. Arch aneurysms were defined as involvement of two
or more arch vessels. PDTA involved only the left subcla-
vian artery without abdominal extension. TAAA included
aortic aneurysms distal to the left that involved the thora-
coabdominal aorta (Fig 1).
Primary outcomes measured were 30-day and in-hos-
pital morbidity and mortality and late survival. Secondary
end points included early and late endoleaks, and graft
patency. The Social Security Death Index was used to in-
vestigate mortality for patients lost to follow-up. Follow-up
CT scans were conducted at 1, 6, and 12months and yearly
thereafter to monitor endoleaks and aneurysm sac geome-
try. Duplex ultrasound imaging or CT scan, or both, was
used to determine visceral and renal bypass graft patency.
General anesthesia was used for all procedures. Preop-
erative spinal drainage to prevent cord ischemia was used
selectively based on a combination of surgeon preference,
patient history of aortic surgery, and anticipated length of
coverage. For thoracic aneurysms requiring subclavian cov-
erage, revascularization of the left subclavian artery was
performed routinely except in emergent cases. A two-stage
hybrid procedure with initial aortic debranching and inter-
val endovascular repair at a separate setting was the pre-
ferred approach. Single-stage hybrid repairs were reserved
for emergent presentations and select cases involving com-
plex arch morphology where aortic arch debranching was
followed by antegrade delivery of the endoprosthesis
through a graft conduit.
Arch debranching techniques, as described by Kieffer et
al,3 were used to create proximal landing zones. Using the
classification of proximal landing zones proposed by Ishi-
maru,4 innominate and left common carotid artery de-
branching was performed for all zone 0 cases, with revas-
cularization of the left subclavian artery in select cases. For
zone 1 cases, a cervical carotid-carotid bypass using a
retroesophageal tunnel or a direct aorta-carotid bypass was
performed in association with left subclavian revasculariza-
tion by transposition or bypass. For descending thoracic
aneurysms requiring zone 2 landing, left subclavian artery
transposition to the left common carotid artery, with over-
sewing of the subclavian artery stump, was routinely per-
formed. Subclavian artery bypass was reserved for patients aith a history of coronary artery revascularization using the
eft internal mammary artery.
Visceral/renal debranching was done through a mid-
ine transperitoneal or an oblique retroperitoneal exposure,
epending on surgeon preference. Multibranched Dacron
rafts were used as retrograde extra-anatomic bypass con-
uits. The preferred inflow was native common left iliac
rtery. In patients with a diseased iliac artery or prior
bdominal aortic surgery, the infrarenal aorta or existing
nfrarenal aortic graft or the iliac limb of a previously placed
ig 1. Preoperative computed tomography image shows a pa-
ient with a type V thoracoabdominal aortic aneurysm.ortobifemoral graft was used for inflow. In selected cases,
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July 201132 Ham et alan aortic replacement performed at the time of visceral/
renal debranching was used for graft inflow.
Anastomoses to the renal arteries were end-to-end with
the proximal stump oversewn. The branch grafts to the
superior mesenteric artery (SMA) and celiac were laid in a
“lazy C” configuration with the branch to the celiac tun-
neled retropancreatically (Fig 2,A and B). Both grafts were
sewn end-to-side. Origins of the native visceral arteries
were occluded with large clips or were ligated with suture
proximal to the end-to-side anastomosis. For transabdom-
inal approaches, the retroperitoneum was closed, when
possible, to cover the prosthetic grafts. Omental flaps were
not routinely used. Retroperitoneal exposures did not re-
quire additional coverage over the grafts.
All endovascular repairs were performed using com-
mercially available endografts under general anesthesia (Fig
3). Endografts were deployed retrograde through femoral
access or by conduit for small diameter (7 cm) iliac
arteries. Antegrade deployment was used in select cases
involving arch aneurysm repairs. Endovascular technical
success was defined by complete exclusion of the aneurysm,
without type I or III endoleak on completion angiography
and without need for conversion to an open procedure.
Statistical analysis was performed using SPSS 17.0 soft-
ware (SPSS Inc, Chicago, Ill). Continuous variables are
summarized as mean  standard deviation. Categoric vari-
ables are expressed as frequency and percentage. Graft
patency and survival were estimated using Kaplan-Meier
analysis. Analyses were performed on an intention-to-treat
basis for patients who did not undergo both stages of the
procedure.
RESULTS
Arch or visceral/renal artery debranching combined
with endovascular repair was done in 51 patients (33 men,
65%) who were a mean of 70 years. Patient demographics
and comorbid conditions are summarized in Table I.
Eleven patients had chronic obstructive pulmonary disease,
1 requiring supplemental oxygen, 18 (35%) had undergone
a prior open aortic procedure, and the mean SVS risk score
was 4.6. At admission, 20 patients (39%) were symptomatic
with chest, back, or abdominal pain.
Preoperative anatomy and clinical features are summa-
rized in Table II. Twenty-seven patients (53%) had an arch
(n 16) or PDTA (n 11). The 24 patients with a TAAA
had a Crawford/Safi classification as follows: types I to III,
3 (13%); type IV, 12 (50%); and type V, 9 (37%); and 5
patients (10%) had a para-anastomotic aneurysm, which
accounted for 4 type IV and 1 PDTA. Of the 12 patients
with type IV TAAA, 9 had undergone previous aortic
operations: 7 for infrarenal AAA, 1 for ascending thoracic
aneurysm, and 1 for both. Chronic dissection was present
in 11 patients (22%).
Thirty-five patients (69%) underwent hybrid repair
electively, and the remaining required urgent (26%) or
emergent repair (6%). A total of 124 vessels were de-
branched, including 47 arch and 77 visceral/renal (Table
III). Of the 47 arch vessels debranched, 11 single-vessel debranchings of the left subclavian artery were performed
y transposition or bypass. All patients with TAAA under-
ent at least a two vessel debranching, with 75% requiring
hree to four vessel debranching. Concomitant aortic re-
onstructions were performed at the time of debranching,
ncluding aortobiiliac/femoral bypass in five, infrarenal an-
urysm repair in one, and ascending aortic replacement in
wo. Spinal drainage catheters were placed in 15 patients
efore the endovascular repair and were removed 48 hours
fter the procedure. No spinal drains were placed in the
ostoperative period.
Most of the hybrid procedures (75%) were staged, with
mean interval between stages of 28 days. Patients with
onruptured symptomatic aneurysms (39%) were initially
anaged with intravenous control of hypertension, present
n 90%, with resolution of pain in most cases. Subsequent
ndovascular repair was performed on the same admission,
ithin a mean of 8 days.
Four patients, two urgent and two elective, did not
ndergo endovascular repair after aortic debranching. The
rst patient, with one functioning kidney, presented with a
ymptomatic type V TAAA. He underwent urgent de-
ranching of the right renal artery and SMA. The renal
ypass graft occluded. He was discharged on permanent
ialysis and is awaiting endovascular repair. Two patients
nderwent successful debranching but refused the staged
ndovascular repair. They are both alive. The final patient
resented with a symptomatic type II TAAA. Bowel isch-
mia developed after visceral/renal debranching, and the
atient died before endovascular repair.
Two patients died for a 30-day and in-hospital mortal-
ty rate of 3.9% (Table IV), with one death each for patients
ith arch and TAAA. One death occurred in a patient with
ruptured arch aneurysm who underwent ascending aortic
ypass to the left common carotid artery and concomitant
ndovascular repair with coverage of the left subclavian
rtery. On postoperative day 6, the patient became acutely
ypotensive. A CT scan revealed aneurysm rupture and the
atient died before reintervention. The second death was
he abovementioned patient with a type II TAAAwho died
fter the debranch procedure.
Overall, 20 patients (39%) experienced one or more
ajor postoperative complications for 30 days or during
ospitalization for either stage of the hybrid repair (Tables
V and V). Thirty-day/in-hospital complications occurred
n 8 patients (50%) with arch aneurysms, 1 patient (9%)
ith PDTA, and 11 patients (46%) with TAAA. Pulmonary
nd renal complications were most frequent, occurring in
% of patients. Paraplegia occurred 1 week after hybrid
epair in a patient (2%) with a type I TAAA, who did not
eceive spinal drainage due to the urgency of operation.
araplegia resolved over 3 months. One patient, who ex-
erienced an acute cerebral infarct seen on magnetic reso-
ance imaging, was readmitted 30 days with complaints
f headache and without other cognitive/motor/sensory
eficits. Another patient suffered hypoxic brain injury with
inimal residual neurologic function after a failed arch
ebranching procedure. Procedural complications ac-
JOURNAL OF VASCULAR SURGERY
Volume 54, Number 1 Ham et al 33Fig 2. After four-vessel debranching of the visceral and renal aorta. A, Computed tomography axial image demon-
strates four limbs of the bypass grafts. LRA, Left renal artery;RRA, right renal artery; SMA, superior mesenteric artery.
B, A 3-dimensional reconstruction displays blood flow through the four-vessel bypass grafts.
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July 201134 Ham et alcounted for 26% of the overall morbidity and included
bleeding in six, graft occlusion in four; endoleak reinterven-
tion, false aneurysm, and wound infection in two each; and
iliac conduit infection in one (Table V).
Of the 24 patients who underwent visceral/renal de-
branching for TAAA, 9 with retroperitoneal exposures
experienced 11.1% complications from the debranching
procedure compared with 46.7% complications in the 15
patients with midline transperitoneal approaches. One pa-
tient in the retroperitoneal group experienced one compli-
cation, whereas five of seven patients with transperitoneal
exposures experienced more than one postoperative com-
plication. Between the two different exposures for visceral/
renal revascularization, the mean length of hospital stay was
9.2 days for the retroperitoneal approach vs 22.4 days for
the midline transperitoneal approach.
Of the 124 bypass grafts performed, 4 graft occlusions
occurred in the postoperative period; 3 renal and 1 carotid.
Two were successfully revised with no untoward sequelae.
The remaining two graft occlusions were not revised. One
Fig 3. After hybrid repair of a type V thoracoabdominal aortic
aneurysm. Three-dimensional reconstruction demonstrates the
four-vessel bypasses to the visceral/renal aorta and endovascular
exclusion of the thoracoabdominal aneurysm.occluded graft to a small kidney with a preexisiting oc- fluded renal artery did not require revision. Renal failure,
equiring permanent dialysis, developed in another patient
ith one functioning kidney after a renal graft occluded.
Technical endovascular success was 87%, comprising
ix type I endoleaks on completion angiogram, all of which
esolved without intervention by postoperative CT scan
btained 30 days. Five endoleaks (2 type I, 3 type II)
ccurred in the hospital. Reintervention was required for
ne type I and one type II endoleak. The first patient
nderwent a carotid-carotid bypass and endovascular repair
able I. Demographic and patient characteristics
haracteristics No. (%) or Mean  SD
atients, total 51
en 33 (64.7)
ge, years 70  10.1
iabetes mellitus 8 (15.7)
obacco (history or current) 35 (68.6)
AD/MI 19 (37.3)
ongestive heart failure 2 (3.9)
ypertension 46 (90.2)
OPD 11 (21.6)
Home oxygen 1 (2)
enal insufficiencya 12 (23.5)
Dialysis-dependent 2 (3.9)
odified SVS risk score 4.6  2.0
rior aortic surgery 18 (35.3)
Thoracic aorta 5 (27.8)
Abdominal aorta 12 (66.7)
Thoracoabdominal aorta 1 (5.6)
ollow-up, months 13.3  12.5
Median (range) 8.4 (0.2-38.4)
AD, Coronary artery disease; COPD, chronic obstructive pulmonary dis-
ase; MI, myocardial infarction; SD, standard deviation; SVS, Society for
ascular Surgery.
Serum creatinine 1.5 mg/dL and includes dialysis-dependent patients.
able II. Preoperative anatomy and clinical features
ariable No (%) or Mean  SD
atients, No. 51
horacic 27 (53)
Arch 16 (59.3)
PDTAa 11 (40.7)
horacoabdominal 24 (39.2)
TAAA extentb
Types I-III 3 (13)
Type IV 12 (50)
Type V 9 (37)
ssociated chronic dissection 11 (21.6)
neurysm diameter, cm (minor axis) 6.1  1.3
linical presentation
Symptomatic 20 (39.2)
Elective 35 (68.6)
Urgent nonruptured 13 (25.5)
Ruptured 3 (5.9)
TDA, Proximal descending thoracic aorta; TAAA, thoracoabdominal aor-
ic aneurysm.
Left subclavian artery revascularization only.
Crawford classification modified by Safi.or an arch aneurysm. A type I endoleak was detected and
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Volume 54, Number 1 Ham et al 35managed by an aorta-innominate bypass with an endovas-
cular proximal extension. Another patient underwent a
four-vessel visceral/renal debranching uneventfully. Dur-
ing the endovascular stage, 14 days later, a type II endoleak
was seen originating from the SMA that had been clipped
during the debranch procedure. The SMA origin was coil
embolized at the time of endovascular repair. The remain-
ing type I and 1 type II endoleaks resolved without inter-
vention. One type II endoleak from an intercostal artery
remains stable.
Primary graft patency was 95.3% at 1 and 3 years (Fig
Table III. Debranched vessel summary
Arch/PDTA No. (%)
Total vessels debranched 47 (37.9)
Left SCAa 22 (46.9)
Transposition 17
Bypass 5
Left CCA 17 (36.2)
Carotid–carotid 9
Aorta–carotid 8
Innominate 8 (17)
Total bypasses performed 124
CCA, Common carotid artery; CIA, common iliac artery; PDTA, proximal
artery.
aIncludes single-vessel left SCA revascularizations for proximal descending t
bInflow based on previously placed aortic graft.
Table IV. Thirty-day and in-hospital complications and d
Complication
Arch n  16
No. (%)
Peri-op death (30-day/in-hospital) 1 (6.3)
Aneurysm rupturea 1
Bowel ischemia . . .
Procedural complication, pts 4 (25)
Neurologic 1 (6.3)
Paraplegia . . .
Stroke 1 (6.3)
Cardiac 1 (6.3)
Atrial fibrillation 1
Pulmonary 3 (18.8)
Pneumonia 1
Respiratory failure/tracheostomy 2
Renal 1 (6.3)
Contrast nephropathyb 1
Renal failure requiring dialysis . . .
Gastrointestinal 1 (6.3)
Small-bowel obstruction . . .
Bowel ischemia . . .
Clostridium difficile colitis 1
Total with 1 complication 8 (50)
PDTA, Proximal descending thoracic aneurysm; TAAA, thoracoabdominal
aAneurysm rupture occurred after endovascular repair.
bSerum creatinine 1.5 mg/dL with subsequent resolution without dialysi4). One late occlusion of a bypass graft to the SMA was tound on the 3-month CT scan. Further intervention was
ot pursued due to adequate collateralization by the celiac
rtery and absence of symptoms.
Five late type II endoleaks were detected on follow-up
maging, of which three required reintervention. Branch
ource of the endoleaks included: three subclavian, one
MA, and one lumbar. Owing to aneurysm expansion, one
ubclavian and one SMA were ligated, and one subclavian
as embolized. There has been no known aneurysm rup-
ure in any patient during the follow-up period.
There were seven late deaths (four aneurysm unrelated,
Thoracoabdominal No. (%)
Total vessels debranched 77 (62.1)
Visceral 43 (55.8)
Celiac 21
SMA 22
Renal 34 (44.2)
Unilateral 8
Bilateral 13
Inflow
Left CIA 5
Right CIA 5
Infrarenal aorta 4
Aortobiiliac/femoralb limb 3
Infrarenal aortic graftb 5
ding thoracic aneurysm; SCA, subclavian artery; SMA, superior mesenteric
ic aneurysms.
PDTA n  11 TAAA n  24 Total N  51
No. (%) No. (%) No. (%)
. . . 1 (4.2) 2 (3.9)
. . . . . . 1 (2)
. . . 1 1
1 (9.1) 8 (33.3) 13 (25.5)
1 (9.1) 1 (4.2) 3 (5.9)
. . . 1 (4.2) 1 (2)
1 (9.1) . . . 2 (3.9)
. . . 1 (4.2) 2 (3.9)
. . . 1 2 (3.9)
. . . 1 (4.2) 4 (7.8)
. . . 1 2 (3.9)
. . . . . . 2 (3.9)
. . . 3 (12.5) 4 (7.8)
. . . 0 1 (2)
. . . 3 3 (5.8)
. . . 2 (8.3) 3 (5.8)
. . . 1 1 (2)
. . . 1 1 (2)
. . . . . . 1 (2)
1 (9.1) 11 (45.8) 20 (39.2)
aneurysm.desceneath
aortichree indeterminate) during a mean follow-up of 13.3 
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July 201136 Ham et al12.5 months. Two patients died secondary to sepsis and
another of respiratory failure at an another facility. One
patient who underwent visceral/renal debranching at our
institution and with subsequent endovascular repair at an-
other institution died of complications of bowel ischemia.
Overall, seven patients were lost to follow-up, of which
three died at 22, 30, and 40 months after the debranching
procedure from undetermined causes. Their last follow-up
CT scan was 9, 23, and 38 months, respectively, and did
not show endoleaks or growth in aneurysm size. Of the
remaining four, three patients were lost before 1 year and
one patient was lost at 30 months. All are confirmed to be
alive by the Social Security Death Index. For all patients, 1-
and 3-year actuarial survival was 86% and 67%, respectively
(Fig 5). For patients with arch aneurysm, 1- and 3-year
actuarial survival was both 80%. For PDTA, 1- and 3-year
actuarial survival was both 100%. For patients with TAAA,
the corresponding 1- and 3-year actuarial survival was 84%
and 54%, respectively.
DISCUSSION
Operative mortality and morbidity of open repair for
aortic arch, thoracic, and TAAA have improved signifi-
cantly at selected centers over the past 20 years. Favorable
Table V. Thirty-day and in-hospital procedural complicat
Procedural complication
Arch n  16
No. (%)
Bleeding 5 (31.3)
Number of graft occlusions 1 (2.9)
Endoleak reintervention (in-hospital) 1 (6.3)
Type I 1 (6.3)
Type II 0
Pseudoaneurysm 1 (6.3)
Wound infection 0
Groin wound infection . . .
Ilial conduit infection . . .
Patients, totald 5 (31.3)
PDTA, Proximal descending thoracic aneurysm; TAAA, thoracoabdominal
aThirty-day and in-hospital complications include any complications that oc
bAll required reintervention for management.
cPercentage based on 124 bypass grafts performed (36 arch, 11 left subclav
dSome patients had more than one procedural complication.
Fig 4. Kaplan-Meier estimates for bypass graft patency in all
patients at 1 and 3 years. *Standard error is10% at all data points.results have been achieved in centers of excellence, with iperative mortality of 3.9% to 9.3% for open arch replace-
ent5-8 and 4.6% to 10% for TAAA repair.9-14 Despite
hese reports, however, real world operative mortality re-
ains significant, 20% for open TAAA repair, based on
he National Inpatient Sample database.15
After the introduction of thoracic endovascular devices,
hybrid approach to arch and TAAA disease has been
dopted as an alternative and potentially less morbid tech-
ique.1,16-24 The first hybrid approach to treat aortic aneu-
ysmal disease was reported in 1999.25 Single-institution
eries since then have reported early-term to medium-term
utcomes with varying results. In general, institutional
eports have shown that aortic debranching, followed by
ndovascular aneurysm exclusion, is effective and feasible
or the treatment of arch and TAAA.1,5-8,17,21,26-30 Re-
orted operative mortality and neurologic complications
paraplegia and stroke) have been acceptable and in some
eports are superior to traditional open repair. Zhou et al29
eported a recent experience using hybrid techniques in 31
atients, where approximately half had arch and half with
arying extent TAAA. All patients had significant comor-
idities, making them high-risk for open repair. The 30-day
utcomes included mortality of 3.8% and morbidity of
9.2%, which included two type II endoleaks and two renal
raft occlusions, all of which were managed without reop-
ration. There was no paraplegia or stroke. A smaller series
y Hughes et al27 reported similar favorable short-term
utcomes in patients with arch or TAAA, including no
erioperative or late deaths and no paraplegia or stroke.
Our collective results mirror these results in low oper-
tive mortality of 3.9% and minimal paraplegia rate of 2%
nd stroke rate of 4%. Our morbidity was higher, at 39%,
ith procedurally related, renal, and pulmonary complica-
ions occurring most frequently. The higher morbidity in
ur series is due in part to the high prevalence of patients
equiring urgent and emergent operations. Collectively,
hese patients had more than half of the observed compli-
ations. In addition, the mean modified SVS score of 4.6
PDTA n  11 TAAA n  24 Total N  51
No. (%) No. (%) No. (%)
. . . 1 (4.2) 6 (11.8)b
. . . 3 (3.9) 4 (3.2)c
. . . 1 (4.2) 2 (3.9)b
. . . 0 1
. . . 1 (4.2) 1
1 (9.1) 0 2 (3.9)b
. . . 2 (8.3) 2 (3.9)b
. . . 2 (8.3) 2
. . . 1 (4.2) 1
1 (9.1) 7 (29.2) 13 (25.5)
aneurysm.
during both hospitalizations for debranching and endovascular repair.
ery, 77 visceral/renal).ionsa
aortic
curredndicates a medically compromised patient population.
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Volume 54, Number 1 Ham et al 37Moreover, a significant number of patients had prior aortic
surgery (35.3%), which as reported by Chiesa et al,31 is
associated with an increase in perioperative morbidity after
hybrid repair.
Disappointed with our outcomes with open TAAA
repair in older high-risk atherosclerotic patients, we
adopted the hybrid debranching procedure in 2005. As a
referral center, this report represents a group of high-risk
patients (mean modified SVS score of 4.6) with atheroscle-
rotic-mediated TAAA. Our current practice with athero-
sclerotic TAAA is managed with the hybrid procedure,
reserving open repair for patients with connective tissue
disorders or younger patients with atherosclerotic TAAA
who have a low-risk profile.
Our approach for arch aneurysms has evolved as well.
Total aortic arch replacement using hypothermic extracor-
poreal circulation and selective cerebral perfusion is associ-
ated with significant mortality of 8.5% to 25% and neuro-
logic morbidity of 12.8%.32 Therefore, less invasive
techniques, such as the hybrid approach, have been increas-
ingly used for aneurysmal disease involving the arch. Two
recent large systematic reviews of the literature have sum-
marized single-center outcomes for hybrid arch repair.
Between the two reviews, 30-day mortality was 8.3% and
9%, stroke rate was 4.4% and 7%, and paraplegia was 3.9%
and 0.5%.33,34 The mortality and neurologic outcomes are
consistent with what we observed for patients with arch and
PDTA. Our 30-day and in-hospital rates were similar, with
a mortality of 6.3%, a stroke rate of 6.3%, and no paraplegia.
Among the several advantages of the hybrid procedure
for the treatment of TAAA are the avoidance of thoracot-
omy, single-lung ventilation, division of the diaphragm,
and prolonged visceral and renal ischemia. Recent case
series report satisfactory early mortality rates and a low
Fig 5. Kaplan-Meier estimates for survival for patients
and thoracoabdominal aortic aneurysm (TAAA). †Numincidence of paraplegia or stroke. A literature review of Tybrid TAAA repair, which included 58 patients considered
nfit for open repair, reported operativemortality of 10.7%,
o paraplegia for elective and urgent cases, and a graft
atency of 97.8% over a 14.5-month mean follow-up.35
hree European centers recently published 30-day out-
omes of their collaborative experience using the hybrid
rocedure to treat 107 patients with TAAA. The 30-day
ortality rate was 14.9%, and permanent paraplegia oc-
urred in 8.4%, which is higher than we observed. Renal
orbidity was significant, with 26.2% experiencing renal
ailure that required temporary dialysis.19
The morbidity rates seen in these reports as well as in
ur own series are of concern.16,19,23,26 Because of these
igher-than-expected morbidity rates, some authors have
ecommended better patient selection for use in hybrid ap-
roaches to TAAA.26 Patel et al23 compared the hybrid
pproach with their institutional open surgical controls and
howed significant morbidity and mortality in the hybrid
roup, even for lower-risk patients. These findings reflect
he need for comparative trials against risk-matched open
urgical patients to better define the patients who will
enefit from the hybrid approach.
Paraplegia is the most devastating complication of
AAA repair. Despite extensive research into the cause and
otential prevention of paraplegia, it remains the Achilles’
eel of open TAAA repair. Although the greatest risk of
araplegia is seen with types I, II, and III TAAA, which are
nderrepresented in our series, patients with type IV or V
AAA with a history of aortic surgery with extended seg-
ents of prosthetic aortic graft are subject to a higher risk
f paraplegia compared with patients with type IV or V
AAA with no prior aortic reconstruction. Twenty-one of
he TAAA in our series were type IV/V extent; however, 12
60%) had previously undergone aortic reconstructions.
arch, proximal descending thoracic aneurysm (PDTA),
f patients remaining. *Standard error 10%.withransient paraplegia occurred in one patient (2% overall)
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July 201138 Ham et alwith a type I TAAA. This low rate of paraplegia is the
strongest argument for application of hybrid procedures to
aortic aneurysm pathology, particularly TAAAs that involve
long segments of the aorta and in patients with previous
aortic reconstructions. To minimize the risk of paraplegia,
selective use of preoperative spinal drainage is practiced at
our institution. Spinal drainage was dictated by the operat-
ing surgeon but in general was used in patients with history
of prior aortic surgery, extended length of aortic coverage,
and concomitant hypogastric artery occlusion. Routine left
subclavian artery revascularization was performed to pre-
serve the left vertebral artery contribution to spinal cord
perfusion.
The retroperitoneal approach has been reported to
provide superior aortic exposure and is associated with less
postoperative complications compared with a midline
transperitoneal approach.36,37 Leather et al36 retrospec-
tively compared 299 patients who underwent open infrare-
nal aortic aneurysm repair by either retroperitoneal (2/3)
or transabdominal (1/3) approaches. Intraoperative fluid
and blood replacement, postoperative respiratory support,
length of time in the intensive care unit, and occurrence of
ileus was significantly less in the retroperitoneal group. Our
experience is limited by a small sample size but corroborates
the advantages of the retroperitoneal approach for the
abdominal aortic exposure; however, further comparison
with transperitoneal approaches, specifically in patients un-
dergoing visceral/renal debranching, are required.
We generally stage the repair by a few weeks, allowing
for patient and hemodynamic stabilization. Although a
simultaneous hybrid procedure is preferred in emergent
settings, which also allows direct vascular access for device
delivery, it includes longer operative time and potentially
increases the risk of renal failure from contrast load as well
as renal ischemia time. On the contrary, an obvious disad-
vantage for staging the hybrid procedure is aneurysm rup-
ture during the interval and a patient’s option to reconsider
consent for the endovascular repair, which occurred in two
of our patients. Drinkwater et al20 reported three patients
who died of rupture while waiting a mean of 20 days for
endovascular repair after visceral debranching. Neverthe-
less, we have had a relatively positive experience using a
two-stage approach, with no interval aneurysm rupture,
and reserving one-stage procedures for emergent cases and
selected aortic arch repairs. Currently, either approach has
been used by many centers with no obvious differences in
outcome.
An important determinant for the late success of hybrid
repair is bypass graft patency. Short-term to medium-term
graft patency reported for debranched visceral/renal vessels
are salutary, ranging from 89% to 100% over a mean
follow-up of 4 to 46months.30 Our 3-year primary patency
of 95% is in line with previously published reports, with an
important observation in our series that late graft occlusion
is uncommon. This suggests that one can expect durable
graft patency assuming a technically proficient debranching
procedure. cAlthough we and many others have used the common
liac artery as the primary inflow for visceral and renal
ebranching, inflow site selection should be predicated on
he quality of the vascular segment. Because many patients
equiring renal and visceral debranching have concomitant
ortic disease, the right or left iliac is commonly the only
ocation for inflow; however, we have also successfully used
he aorta, either graft or native.
Prevention of aneurysm rupture, which is the aim of
urgical therapy, appears to be achieved in the medium-
erm using a hybrid approach. Zhou et al29 reported no late
neurysm-related death in 31 patients during a mean
ollow-up of 16 months. Hughes et al27 reported no
eaths, endoleaks, or change in size of aneurysm in 13
atients during amean follow-up of 7.5months.Quinones-
aldrich et al21 reported no aneurysm growth or rupture
ver a mean of 16.6 months and cumulative survival at 2
ears of 76%. A similar survival of 70% at 3 years was
eported by Bockler et al.38 Our 1- and 3-year actuarial
urvival of 86% and 67%, respectively, mirror these results.
Branched endografts, which were first shown to be
echnically feasible by Chuter et al,39 represent yet a third
ption for the treatment of arch and TAAA. They reported
arly results of 22 patients with TAAA all treated with
ranched endografts. All grafts were successfully deployed.
erioperative mortality was 9.1%, morbidity occurred in
1%, with a 9.1% early reintervention rate for endoleak, and
o cases of paraplegia. Visceral artery patency was 98.7% at
month, and one type II endoleak occurred on follow-
p.40
Greenberg and Roselli41 treated 73 patients with
AAA using purely endovascular techniques. Operative
ortality was 5.5% and paraplegia occurred in 2.7%. The
rench recently reported early outcomes from a multi-
enter experience, including 134 patients with TAAA.
heir 30-day mortality was 2%, morbidity was 12%, and the
araplegia and stroke rate was 2.2%.42 Over a median
ollow-up of 15 months, 12 procedurally related reinter-
entions were required for endoleak and threatened visceral
essels. Four renal arteries occluded. The 24-month actu-
rial survival was 86%.
Despite these promising early results, the widespread
pplication of this technique in the United States is limited
y practical and regulatory issues.43 Moreover, other po-
ential barriers to the broad application of branched en-
ografts remain to be addressed, including variability of
rch and visceral and renal anatomy, and need for custom-
ade device fabrication and branch technology in the
rgent and emergent settings.
ONCLUSION
The hybrid procedure is an integration of catheter-
ased technology and traditional surgical techniques. This
ntermediate report shows it provides a durable repair and is
ssociated with a low incidence of paraplegia and death.
urther evaluation and follow-up is required to determine
hat role this approach will have in the future treatment of
omplex aortic aneurysm disease.
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Dr Timothy K. Liem (Portland, Ore). I would like to con-
gratulate DrHam and the vascular group at University of Southern
California (USC) for an excellent presentation and to thank them
for sending me the manuscript in advance. Their experience rep-
resents one of the larger series of aortic debranching procedures,
and their results have added confirmation to our notion that a
hybrid approach for the repair of extensive aneurysmal disease is
not without significant associated morbidity. In fact, the authors
described a 40% morbidity, mostly due to pulmonary and renal
complications, and to a lesser degree, procedural complications
such as bleeding, graft occlusion, and endoleak reintervention.
We perform extensive debranching procedures as well, and
results such as these have tempered our enthusiasm for the hybrid
procedure as a panacea, which would completely replace open
thoracoabdominal aneurysm repair. Depending on how many
vessels require “debranching,” many of you know that these pro-
cedures can be a tour de force, requiring many hours to complete,
with multiple surgical teams.
The existing literature regarding hybrid procedures is for the
most part, limited to single-institution series. The USC group has
presented a largely observational study that mirrors that trend.
They describe the clinical results in a diverse group of patients who
underwent some form of debranching and stent graft placement
for aneurysmal disease of the aortic arch, proximal descending
thoracic aorta, thoracoabdominal aorta, or for para-anastomotic
aneurysms. The term “hybrid procedure” includes a wide spec-
trum of surgeries, ranging from isolated subclavian transposition
or carotid-carotid bypass, performed through small incisions, to
extensive multivessel debranching, requiring sternotomy or large
midline abdominal incisions.
This study is limited by a lack of comparison between groups.
For example, it would have been interesting to compare open vs
hybrid thoracoabdominal aneurysm repairs, or even single vessel vs
multi-vessel debranching procedures, and this leads me to the first
of several questions:
1. How many patients received a single-vessel debranching proce-
dure vs four-vessel debranching? The manuscript did not spec-
ify the number and distribution of debranched vessels, but this
information would be vital to allow comparison between differ-
ing series.
2. Forty percent of the patients had symptomatic aneurysms or
para-anastomotic aneurysms. Yet, 75% of patients underwent
staged procedures with a mean interval of 28 days between the
debranching and the stent graft placement.Was the diagnosis of
symptomatic aneurysm equivocal in some, or is our algorithm
for the urgent treatment of symptomatic aneurysms changing?
3. Your manuscript describes a very respectable graft patency of
93.6% at 1 and 3 years. However, there were four graft occlu-
sions in the postoperative period, involving three renal arteriesdiscovered, and can you expand upon how the revisions were
performed? Since the kidneys do not tolerate lengthy periods of
ischemia, were these revisions performed emergently and how
do you know that renal function was preserved?
. What portion of your descending thoracic aneurysm and tho-
racoabdominal aortic aneurysm practice does this series repre-
sent, and what is your comparative mortality and morbidity
with completely open thoracic and thoracoabdominal aneu-
rysm repair?
Your manuscript cited a recent article from the University of
ichigan group. They performed a retrospective comparison be-
ween total open vs hybrid repair of thoracoabdominal aneurysms,
dentifying that open repair correlated with a higher chance of
ombined mortality and morbidity? Can you give us insights into
hich group of patients would be most suitable for a hybrid
pproach versus total open repair?
I would like to thank the members of the program committee
or giving me the privilege of discussing this paper.
Dr Sung Wan Ham. Only patients with arch or proximal
escending thoracic aneurysm underwent a single vessel deb-
anch. All patients with thoracoabdominal aneurysms under-
ent at least a two-vessel debranch with three-fourths requiring
three- to four-vessel debranch. Of the 27 patients with arch or
escending thoracic aneurysm, including one para-anastomotic
neurysm, 16 underwent a single-vessel debranching procedure
9 left subclavian artery, 7 left common carotid bypass). In
eneral, this cohort of patients did experience less morbidity, as
ll but one single-vessel debranching was performed without
he need for sternotomy.
Symptomatic patients did not have rupture on computed
omography; however, they were debranched expeditiously and
anaged in the intensive care unit with intravenous control of
ypertension, which was present in 90%. Their pain resolved in
ost cases. These patients subsequently underwent the endovas-
ular stage during the same admission within an average of 8 days.
Of the four early graft occlusions, two underwent immediate
evision 24 hours. One patient with preexisting ischemic ne-
hropathy and a solitary kidney became anuric on postoperative 1
nd was emergently taken to the operating room for revision of a
hrombosed renal graft. It is likely that the patient had adequate
ollateralization from long-standing ischemic nephropathy, which
revented permanent ischemic injury. Her renal function im-
roved and she was discharged with a functioning kidney. The
ther patient who underwent a right-to-left common carotid
ypass and developed graft occlusion on postoperative day 5,
efore the endovascular repair. He was taken immediately for
hrombectomy and subsequently underwent an uneventful endo-
ascular repair of the arch aneurysm.
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Volume 54, Number 1 Ham et al 41Our first hybrid procedure was performed to treat a patient
with a type IV thoracoabdominal aneurysm in 2005. Since then,
our techniques have evolved and we have extended the hybrid
approach to treat aneurysms of the proximal descending thoracic
aorta and the arch with relatively low mortality and paraplegiahe literature, with a paraplegia rate of 5% to 10%, depending on
he extent of the TAAA, with a composite incidence of paraplegia,
enal failure, and early death of approximately 20%. Therefore, the
ybrid approach has been our preferred method for treatment of
horacoabdominal aneurysms over the past 2 to 3 years, particu-rates. Although we have not recently analyzed our results with
open repair, historically our results have been what is reported in
larly in the older patient with atherosclerotic thoracoabdominal
aneurysm.
